Source: International Congress 2019 – Basic research of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Huang (Ann Arbor, United States of America), K. Opron (Ann Arbor, United States of America), J. Erb-Downward (Ann Arbor, United States of America), L. Begley (Ann Arbor, United States of America), N. Alexis (Chapel Hill, United States of America), I. Barjaktarevic (Los Angeles, United States of America), G. Barr (New York , United States of America), E. Bleecker (Tucson, United States of America), R. Bowler (Denver, United States of America), S. Christenson (San Francisco, United States of America), A. Comellas (Iowa City, United States of America), C. Cooper (Los Angeles, United States of America), D. Couper (Chapel Hill, United States of America), C. Doerschuk (Chapel Hill, United States of America), M. Dransfield (Birmingham, United States of America), M. Han (Ann Arbor, United States of America), A. Hastie (Winston-Salem, United States of America), E. Hoffman (Iowa City, United States of America), R. Kaner (New York, United States of America), J. Krishnan (Chicago, United States of America), W. O'Neal (Chapel Hill, United States of America), R. Paine 3rd (Salt Lake City, United States of America), S. Peters (Winston-Salem, United States of America), M. Wells (Birmingham, United States of America), P. Woodruff (San Francisco, United States of America), F. Martinez (New York, United States of America), J. Curtis (Ann Arbor, United States of America), G. Huffnagle (Ann Arbor, United States of America). Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort. 3580

Member's Comments

No comment yet.

Related content which might interest you: Lung microbiome dysbiosis is associated with mortality in COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study Source: Eur Respir J 2014; 43: 1289-1297 Year: 2014 Prevalence and clinical characteristics of lung cancer with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005 Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 The study of airway microbiome and mycobiome of COPD and AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results Source: Annual Congress 2012 - COPD exacerbation Year: 2012 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Relationships between lung physiology and airway and systemic inflammation: a cohort study in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Lung core-predominant emphysema is associated with higher symptom burden in COPD: analysis of the COPDGene cohort Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Lung microbiome dynamics in COPD exacerbations Source: Eur Respir J 2016; 47: 1082-1092 Year: 2016 Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Incidence and clinical characteristics of lung cancer in patients with COPD - From Hokkaido COPD cohort study Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Association between functional small airways disease and 3-year change in emphysema in the SPIROMICS cohort Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021 Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Preliminary data from a longitudinal study of the airway microbiome in COPD Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Systemic effects of bronchial colonization in early COPD patients enrolled in the PAC-COPD cohort Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007 Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Sources of origin of the oropharyngeal microbiota in patients with different phenotypes of COPD Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017